Identification of Prognostic Biomarkers by Combined mRNA and miRNA Expression Microarray Analysis in Pancreatic Cancer.

In conclusion, we think that data mining method can do well in biomarker screening, and ECT2 and NRP2 can play as potential biomarker or therapy target by Crispr Cas9 in pancreatic cancer.
PMID: 29631214 [PubMed - as supplied by publisher]

Source: Translational Oncology - April 5, 2018 Category: Cancer & Oncology Authors: Liu B, Yang H, Taher L, Denz A, Grützmann R, Pilarsky C, Weber GF Tags: Transl Oncol Source Type: research